VIR Q1 2026 Earnings Significant EPS Miss as Biotech Continues Investment Phase NTLA Q1 2026 Earnings Narrowerthanexpected loss signals continued progress in gene editing pipeline UNF Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower USAS Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite Negative Surprise TSHA Q1 2026 Earnings EPS Miss Highlights Ongoing DevelopmentStage Challenges RERE Q1 2026 Earnings EPS Surges 712 Above Estimates Stock Declines on Lack of Revenue Details